1. Editor's page

   EditorialNotes Pages: 127 - 127

2. Gonadotropin releasing hormone (GnRH) analogs for the treatment of breast and prostatic carcinoma

   • Richard J. Santen
   • Andrea Manni
   • Harold Harvey

   Eighth San Antonio Breast Cancer Symposium Pages: 129 - 145

3. Tumor nuclear grade, estrogen receptor, and progesterone receptor: Their value alone or in combination as indicators of outcome following adjuvant therapy for breast cancer

   • Bernard Fisher
   • Edwin R. Fisher
   • Contributing NSABP Investigators

   Report Pages: 147 - 160

4. Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancer

   • Rosella Silvestrini
   • Maria Grazia Daidone
   • Gianni Bonadonna

   Report Pages: 161 - 169

5. Cell kinetics of histologic variants ofin situ breast carcinoma

   • John S. Meyer

   Report Pages: 171 - 180

6. Correlation of Fcγ receptors on peripheral blood mononuclear cells and survival in patients with metastatic breast cancer

   • David Ilfeld
   • Joshua Barzilay
   • Maya Ran

   Report Pages: 181 - 186

7. Familial occurrence of breast cancer is associated with reduced natural killer cytotoxicity

   • David R. Strayer
   • William A. Carter
   • Isadore Brodsky

   Report Pages: 187 - 192

8. Menopausal estrogen use and the risk of breast cancer

   • Jill A. McDonald
   • Noel S. Weiss
   • Lincoln Polissar

   Report Pages: 193 - 199

9. Immunological detection and quantitation of alpha transforming growth factors in human breast carcinoma cells

   • Isabelle Perroteau
   • David Salomon
   • James Tam

   Report Pages: 201 - 210

10. Aminoglutethimide-induced myelosuppression

    • J. T. M. van der Heijden
    • T. A. W. Splinter

    Correspondence Pages: 211 - 212

11. Announcement

    Announcement Pages: 213 - 217